Perrigo Co. Plc (PRGO)

14.92 +0.65 (+4.56%) USD  |  NYSE  |  Sep 04, 16:00
14.91 -0.01 (-0.07%) After-Hours: 20:00
More

Perrigo SG&A Expense (TTM) : 997.20M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 997.20M
March 31, 2026 1.019B
December 31, 2025 1.033B
September 30, 2025 1.011B
June 30, 2025 1.037B
March 31, 2025 1.065B
December 31, 2024 1.089B
September 30, 2024 1.159B
June 30, 2024 1.192B
March 31, 2024 1.223B
December 31, 2023 1.249B
September 30, 2023 1.276B
June 30, 2023 1.253B
March 31, 2023 1.259B
December 31, 2022 1.21B
September 30, 2022 1.171B
June 30, 2022 1.173B
March 31, 2022 1.110B
December 31, 2021 1.111B
September 30, 2021 1.155B
June 30, 2021 1.152B
March 31, 2021 1.131B
December 31, 2020 1.126B
September 30, 2020 1.102B
June 30, 2020 1.111B
Date Value
March 31, 2020 1.148B
December 31, 2019 1.166B
September 30, 2019 1.171B
June 30, 2019 1.144B
March 31, 2019 1.129B
December 31, 2018 1.126B
September 30, 2018 1.134B
June 30, 2018 1.159B
March 31, 2018 1.159B
December 31, 2017 1.146B
September 30, 2017 1.161B
June 30, 2017 1.154B
March 31, 2017 1.177B
December 31, 2016 1.206B
September 30, 2016 1.256B
June 30, 2016 1.291B
March 31, 2016 1.332B
December 31, 2015 1.164B
September 30, 2015 967.80M
June 30, 2015 799.20M
March 31, 2015 675.50M
June 30, 2014 546.20M
March 31, 2014 388.86M
December 31, 2013 365.59M
September 30, 2013 264.88M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc 191.46M
Jazz Pharmaceuticals Plc 1.679B
GH Research Plc 24.75M
Cosmo NV 34.02M
Viatris, Inc. 3.981B